Medications - Page 154

October 24, 2015

Don't take niacin for heart health, doctors warn

Niacin, or vitamin B3, is too dangerous and should not be used routinely by people looking to control their cholesterol levels or prevent heart disease, doctors say.

October 24, 2015

Family credits rare medical marijuana with helping epileptic son

A California family says a rare type of medical marijuana has helped control their 7-year-old son’s severe epilepsy, Fox 40 reported.

October 24, 2015

Patients steered to fewer pharmacies may fill more prescriptions

When patients have drug benefits that encourage them to save money by using certain pharmacies, they may end up filling more prescriptions, a company-funded study suggests.

October 24, 2015

Novartis wins early US approval for major new heart drug

Novartis AG on Tuesday won U.S. approval for its keenly awaited new heart failure drug Entresto earlier than expected, boosting hopes for a medicine tipped by analysts to reap billions of dollars in annual sales.

October 24, 2015

Taiwan orders more human vaccine as rabies returns

Taiwan has ordered tens of thousands of vaccine doses to protect people against the island's first rabies outbreak in more than 50 years.

October 24, 2015

Doctors dole out prescriptions for exercise

Patients are coming out of the doctor’s office with prescriptions for physical activity in addition to drugs, doctor referrals and follow-up protocols.

October 24, 2015

Vaccine refusal contributes to whooping cough outbreaks

The 2010 whooping cough outbreak in California may have been fueled, at least in part, by clusters of parents who refused to vaccinate their children, a new study suggests

October 24, 2015

FDA approves first presurgical breast cancer drug

Federal health officials say they have approved a biotech drug from Roche as the first medicine labeled for the treatment of breast cancer before surgery.

October 24, 2015

Express Scripts says costly new cholesterol drugs could 'wreak havoc'

Express Scripts Holding Co, the largest pharmacy benefit manager in the United States, on Wednesday said the cost of potent, newly approved cholesterol drugs could "wreak financial havoc" among its clients.

October 24, 2015

GSK files for US approval of new diabetes drug

GlaxoSmithKline said on Monday it had filed for U.S. approval of its new once-weekly diabetes drug albiglutide and would make a similar submission shortly in Europe as it vies for a share of a crowded market